ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

NIH Reauthorization Lost In The Shuffle As Congress Adjourns; NCI Budget $1.723 Bil.

November 2, 1990

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

Monica Bertagnolli To Succeed Schilsky As CALGB Chairman.

November 21, 2008

Abstracts Of Papers From Gynecologic Oncology Conference

October 10, 1975

NCI Advisors Approve Expansion Of CCOPs, Minority-Based CCOPs; Approve Reissuance Of BMT Network RFA, RFPs For Preclinical Drug Studies

November 13, 2009

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

October 22, 2010